China Life Insurance to Enter Partnership for AI, Semiconductor Niche Investments

MT Newswires Live
Yesterday

China Life Insurance (HKG:2628, SHA:601628), Wuxi China Life Chengda Equity Investment Center (Limited Partnership), and other investors are planning to form a partnership, as limited partners, with China Life Chengda (Shanghai) Healthcare Equity Investment Management as the general partner.

China Life Equity Investment will serve as the manager of the partnership, which will have a six-year term and focus on investments in the artificial intelligence and semiconductor niches, a Thursday bourse filing showed.

The total capital contribution to be made by all partners will be up to 6 billion yuan, of which the company will contribute a maximum of 4.5 billion yuan.

The company will also enter into an ancillary agreement with China Life Chengda (Shanghai) Healthcare Equity Investment Management and China Life Equity Investment to amend certain terms applicable to it in the partnership contract.

The insurer is expected to enter both agreements by Dec. 31.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10